Respiratory Medicine CME
Volume 4, Issue 4 , Pages 151-153, 2011

A 42-year-old man with progressive dyspnea and a rapidly growing mass

Department of Medicine, Division of Pulmonary, Critical Care and Sleep Disorders, University of Louisville and Louisville Veterans’ Administration Medical Center, Louisville, KY 40202, United States

Received 11 May 2011; accepted 25 May 2011.

Article Outline

Abstract 

Malignant fibrous histiocytoma (MFH), also known as undifferentiated high grade pleomorphic sarcoma, accounts for 20–24% of all soft tissue sarcomas in the US. Peak incidence is in the fifth and sixth decades of life, with a 2:1 male to female distribution. MFH is usually seen in the soft tissues of the extremity and involvement of the lung is rare. We report a case of pleural MFH in a patient with previous pleuro-pulmonary tuberculosis for which he had a lobectomy.

Keywords: Malignant fibrous histiocytoma, Mesothelioma, Pleural effusion, Undifferentiated pleomorphic sarcoma

Abbreviations: CD68, Cluster of Differentiation 68, CT, Computed Tomography, MFH, Malignant fibrous histiocytoma, MRI, Magnetic Resonance Imaging

 

Back to Article Outline

1. Clinical summary 

A 42-year-old white man presented with sub-acute onset of weight loss, malaise and pleuritic right sided chest pain. Three years ago he was diagnosed with pleuro-pulmonary tuberculosis for which he underwent a right upper lobectomy in addition to receiving anti-tuberculous therapy. He was an active smoker with a 40 pack-year history of cigarette smoking and drinks beer daily. He denied any illicit drug use or significant occupational exposures. Physical examination was relevant for diminished breath sounds with dullness to percussion posteriorly on the right lower lung zones. Laboratory testing was unremarkable. Chest imaging at presentation (Fig. 1, Fig. 2) demonstrated a loculated right pleural effusion and right sided pleural thickening with nodularity. Thoracentesis revealed the pleural fluid to be an exudate with lymphocyte predominance. Smears, cultures and cytology were negative. Increasing pleural effusions and worsening respiratory status prompted a tube thoracotomy. His clinical condition deteriorated more and he developed respiratory failure requiring mechanical ventilator support. Repeat CT scan (Fig. 3) of the chest revealed rapid expansion of the tumor mass and persistent pleural effusion. A closed pleural biopsy was performed. Microscopic examination of the pleural biopsy (Fig. 4) revealed sheets of pleomorphic epithelioid cells with populations of intermingled spindle shaped cells. A high mitotic rate and marked necrosis were noted. Immunohistochemical staining profile demonstrated no definable line of differentiation. Electron microscopy did not demonstrate any microvilli. Given these findings, a diagnosis of malignant fibrous histiocytoma was made. Our patient subsequently developed ventilator associated pneumonia and septic shock. His tube thoracotomy continued to drain more than 1 L each day. He was clinically unstable for any aggressive surgical intervention. He had an unfavorable course, developing multi-organ failure and passed away 3 weeks following admission. Autopsy revealed a tan, 35 × 27 × 10cm, fleshy, focally hemorrhagic mass encasing the right hemithorax (Fig. 5), from the apex of the chest cavity to the diaphragm inferiorly and to the anterior and posterior mediastinum medially. The tumor displaced the heart to the left by 5 cm. Arising from the pleura grossly, this tumor passed through the oblique fissure of the right lung. The previous upper lobectomy site, as evidenced by a surgical staple line, was also surrounded by the mass. Aortic adventitia, esophageal adventitia, pericardium and the crux of the diaphragm were all involved by the tumor. The cut surface of the tumor demonstrated soft, variegated, and pale-tan to hemorrhagic tumor parenchyma.

  • View full-size image.
  • Fig. 3 

    CT scan of the chest (3 weeks subsequent to presentation). CT chest (without IV contrast) showing increasing thickening and nodularity of the pleura, along with the large pleural effusion.

  • View full-size image.
  • Fig. 4 

    Pleural biopsy. Hematoxylin and Eosin stained (A, B) pleural biopsy sections at 40x magnification showing pleomorphic spindles and epithelioid populations. Electron micrograph (C) showing cytoplasmic primary and secondary lysosomes and lack of villi on tumor cell surfaces (microvilli are specific for mesothelial cells).

  • View full-size image.
  • Fig. 5 

    Gross pathology (Autopsy). Autopsy revealed a tan, 35 × 27 × 10 cm fleshy, focally hemorrhagic mass encasing the right hemithorax, from the apex of the chest cavity to the diaphragm inferiorly and to the anterior and posterior mediastinum medially.

Back to Article Outline

2. Discussion 

MFH was first described by O’Brien and Stout1 in 1964. MFH most commonly occurs in the soft tissue of the extremities, especially lower extremities.2 Similar to other soft tissue sarcomas, malignant fibrous histiocytoma mainly metastasizes via the hematogenous route to the lung, liver, and bone.2, 3 While the lung is a common site for metastatic involvement of MFH, primary involvement is rare, with approximately 60 cases reported in the English literature. Primary MFH of the pleura is rarer, with only 5 cases4, 5, 6, 7, 8 reported in the English literature to date (Table 1). Risk factors include previous radiation exposure, shrapnel injury, pulmonary/pleural tuberculosis and implanted metallic devices. Common clinical presentation is a slowly enlarging painless mass, with occasional reports of rapid expansion of tumor. CT scans typically reveal a large, lobulated, soft tissue mass of predominantly muscle density, with nodular and peripheral enhancement of solid portions. Central areas of low attenuation may be present, corresponding to myxoid regions, old hemorrhage, or necrosis. Fat attenuation is not observed in the tumors, which can distinguish tumors from some well-differentiated liposarcomas. MRI is useful when surgery is planned, helping to identify chest wall or pericardial involvement. The main treatment is wide margin surgical excision (extrapleural pneumonectomy) with or without adjuvant radiation or chemotherapy.

Table 1. Reported cases of Malignant Fibrous Histiocytoma (English literature).
Age (yrs)SexTumor sizeSurvivalaPresenting symptomsPleural effusionComments
61F24 cms2 yrsDyspnea+Hepatic metastasis noted 18 months after surgery4
62Fb2 yrsCough+Had cardiac tamponade due to tumor invasion5
65M12 cmsAlive 4 yrs follow upFever, fatigueFrom initial evaluation, the mass was stable for 7 years, with increase in size and removal 8 years later6
51F8 cmsAlive 14 days post-surgeryDyspnea, fever+Had a stable mass for 23 years, with rapid increase in size after that7
86M10 cms13 yrsIncidental+Slow growing mass noted when patient had surgical evaluation for peptic ulcer disease8

aSince initial tumor presentation.

bNot mentioned, circumferential pleural thickening was present with multiple nodules on the pleura.

Diagnosis of MFH depends heavily on histology and exclusion of other more specific sarcomas by immunohistochemical stains and additional ancillary studies. MFH shows no definitive lines of differentiation. Microscopic examination of MFH demonstrates sheets of epithelioid appearing pleomorphic cells with eosinophilic or foamy cytoplasm and eccentrically located large nuclei. Typically a high mitotic rate and marked tumor necrosis are present. Immunohistochemical stains demonstrate a strong, diffuse intracytoplasmic staining for vimentin, alpha-1 antitrypsin, alpha-1 antichymotrypsin, CD68 and intense cytoplasmic staining for lysozyme. Electron microscopy reveals cells with histiocytic-like or fibroblast-like features showing pseudopodia with abundant primary and secondary lysosomes, ribosomes and some mitochondria. The nuclei of the tumor cells are large and irregular or indented. Both spindle and epithelioid shaped tumor cells are observed. The most important differential in this case is mesothelioma. Mesotheliomas stain positive for cytokeratin 5/6 and calretinin, as well as demonstrate microvilli on electron microscopy as compared to MFH.

Back to Article Outline

3. Conclusion 

MFH of the pleura is rare, with a varied presentation. It is usually a slow growing tumor and the histology does not correlate with its clinical behavior. The main prognostic factors are the degree of invasion of adjacent structures at the time of diagnosis. Complete excision is the treatment of choice, with long term follow up required evaluating recurrence.

Back to Article Outline

Conflicts of interest 

We have no conflicts of interest to disclose.

Back to Article Outline

References 

  1. O’Brien JE, Stout AP. Malignant fibrous xanthomas. Cancer. 1964 Nov;17:1445–1455
  2. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer. 1978 Jun;41(6):2250–2266
  3. Enzinger FM. Malignant fibrous histiocytoma 20 years after Stout. The American Journal of Surgical Pathology. 1986;10(Suppl. 1):43–53
  4. Bini A, Grazia M, Stella F, Petrella F, Bazzocchi R. Giant malignant fibrous histiocytoma of the pleura arising from solitary fibrous tumour. Thorax. 2004 Jun;59(6):544
  5. Nishimura T, Fujiyoshi Y, Nagayama K, Tanaka T, Tanimura A. A case of malignant fibrous histiocytoma of the pleura. The Kurume Medical Journal. 1985;32(3):223–227
  6. Rizkalla K, Ahmad D, Garcia B, Hutton L, Novick R, Keeney GL. Primary malignant fibrous histiocytoma of the pleura. A case report and review of the literature. Respiratory Medicine. 1994 Oct;88(9):711–714
  7. Sforza V, del Vecchio MT, Gotti G, Tucci E, Santopietro R. Primary malignant fibrous histiocytoma of the pleura. A case report. Applied Pathology. 1986;4(3):162–169
  8. Yang HY, Weaver LL, Foti PR. Primary malignant fibrous histiocytoma of the pleura. A case report. Acta Cytologica. 1983 Nov-Dec;27(6):683–687

 Facility: The work described below was performed at the University of Louisville.

PII: S1755-0017(11)00039-X

doi:10.1016/j.rmedc.2011.05.002

Respiratory Medicine CME
Volume 4, Issue 4 , Pages 151-153, 2011